Side-by-side financials for ABOS and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABOS | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$121.33M | -$1.13B |
| SEC filings | 336 | 782 |
Full pages: Acumen Pharmaceuticals, Inc. and Revolution Medicines, Inc., or browse the full rankings.